alexa

GET THE APP

Immunotherapy for Hepatocellular Carcinoma and Its New Development | OMICS International| Abstract

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Oncol Res Treat 2019, Vol 4(1): 134

Immunotherapy for Hepatocellular Carcinoma and Its New Development

Heping Li1, Ildiko Gyory2, Xiaoli Zhang3, Mingyan Xu3 and Shiqiu Xiong4*
1Department of Medical Oncology, First affiliated hospital, Sun Yat-sen University, Guangzhou, China
2Department of Molecular and Cell Biology, University of Leicester, UK
3HaploX Biotechnology Co. Ltd, Shenzhen, China
4LGC Limited, Fordham, Cambridgeshire, CB75WW, UK
*Corresponding Author : Shiqiu Xiong Senior Investigator, LGC Ltd, Molecular Biology, Fordham, Cambridgeshire, CB75WW.UK, UK, Tel: 00447449965484, Email: [email protected]

Received Date: Jan 18, 2019 / Accepted Date: Feb 11, 2019 / Published Date: Feb 18, 2019

Abstract

Hepatocellular Carcinoma (HCC) is the most common primary liver cancer with high mortality. Because of the limitation on the conventional therapeutic options and immunological characters of this disease, variable immunotherapy strategies for HCC have been designed and investigated. A few of them look promising. In this review, we comprehensively summarized recent and novel immunotherapies for HCC, with a particular focus on clinical trials on the basis of their physiological rationales for these strategies. Insights into these clinical progress and their ideologies are essential to improve efficacy and clinical outcome of these immunotherapies

Keywords: Hepatocellular carcinoma; Immunotherapy; liver tolerance; Clinical trial

Citation: Li H, Gyory I, Zhang X, Xu M, Xiong S (2019) Immunotherapy for Hepatocellular Carcinoma and Its New Development. J Oncol Res Treat 4: 134.

Copyright: © 2019 Li H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1673
  • [From(publication date): 0-0 - Apr 16, 2021]
  • Breakdown by view type
  • HTML page views: 1561
  • PDF downloads: 112
Top